Jonathan Evans
Chief Investment Officer @ Temerity Capital Partners
Los Angeles, United States
Jonathan Evans is a Series A investor at Temerity Capital Partners in Los Angeles focused on SaaS and FinTech. Jonathan Evans is the Co-Founder and General Partner at Flexcap Ventures. He attended Harvard Business School and Georgetown University.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Jonathan Evans invests in
Stages Jonathan Evans invests in
Countries Jonathan Evans invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- SaaS 2 (29%)
- FinTech 2 (29%)
- Software 2 (29%)
- Health Care 2 (29%)
- Apps 1 (14%)
Stage
- Series A 3 (43%)
- Venture - Series Unknown 2 (29%)
- Seed 1 (14%)
- Series B 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Professional Fighters League is a mixed martial arts league. | $28M / Series B / Aug 08, 2018 | ||
| Luma Health patients should be able to connect to their healthcare provider in a way that’s modern and mobile-first. Their services include healthcare, patients, appointments, scheduling, patient messaging, patient engagement, patient communication, public health, patient access, and more. | $6.3M / Series A / May 22, 2018 | ||
| EquipmentShare is a construction solutions provider dedicated to solving industry pain points through smart jobsite technology and equipment rental, retail, and service centers. EquipmentShare’s cloud-connected platform, T3, is powered by telematics and machine hardware to give construction and industrial companies a real-time view of their jobsiteand operations. EquipmentShare’s enterprise suite of apps is OEM-agnostic and can track and manage any piece of equipment, regardless of brand, to help fleet managers monitor assets, prevent theft and machine misuse, track employee hours and shifts, increase machine utilization, streamline maintenance and prevent unplanned downtime. Founded in 2015, EquipmentShare operates 153 facilities as of year-end and employs approximately 4,000 team members of diverse perspectives who push the boundaries of possibilities to create unparalleled customer value, support their communities and empower construction professionals to work more efficiently. EquipmentShare’s growing presence of locations, which includes equipment and service yards, research and development sites, dealerships for major brands, administrative offices, and specialty solutions locations, serves the rising demand for the company’s equipment and digital solutions. | Venture - Series Unknown / Jan 15, 2018 | ||
| ClearGraph provides enterprise search solutions to make data accessible to business users at massive scale. The ClearGraph proprietary semantic search platform uses context awareness and natural language processing to intelligently interpret and answer english language queries, making finding and understanding enterprise data as easy as search. | Seed / Mar 29, 2017 | ||
| Exactuals is a SaaS-based platform that assists enterprises in paying non-employees.The platform registers its clients' data, calculates payments based on preferences, aggregates payment data, and distributes deposit payments to non-employees. It features identity vault, automated workflow, aggregated payments, real-time transparency,centralized identity management, direct deposit, and tax centers. It offers its services to firms in the music and film industries.Exactuals was launched in 2011 by Mike Hurst and is based in California. | $10M / Series A / Feb 08, 2017 | ||
| BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform. BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated AntibodyOptimization (CIAO!) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow them to develop novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment, even when the target is also found in normal tissue, not only improves safety but also expands the universe of potential drug targets, enabling the treatment of previously untreatable cancers. | $39M / Venture - Series Unknown / Jul 21, 2015 | ||
| Glia is the leader and pioneer of Unified Interaction Management—redefining how companies interact with their customers. The Glia Interaction Platform unifies voice, digital customer service, and AI with a unique ChannelLess® architecture that eliminates data silos, dropped context, and frustration for customers and representatives. With Glia,companies can easily shift volume between channels, and customer connections can evolve naturally. Glia helps its customers harness the power of customer interactions to drive efficiency, loyalty, and revenue.Glia has partnered with over 500 insurance companies, banks, credit unions, and other financial institutions worldwide to improve the customer experience and drive business results. Named a Deloitte Technology Fast 500™ company for a fifth year in a row and a Great Place to Work (with a 97% employee satisfaction rating), the company has raised over $150 million in funding from top investors and was recently valued at over $1 Billion. Learn more at glia.com. | $7.6M / Series A / Jul 09, 2015 |
Co-Investors
Temerity Capital Partners is a family office and private investment company investing across the capital structure in public and private companies as well as direct real estate.
Temerity Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Sandler
Chairman, Founder and CEO
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jonathan Evans invest in?
Jonathan Evans invests primarily in SaaS, FinTech and Software startups, most often at Series A and Venture - Series Unknown stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jonathan Evans?
Public channels for Jonathan Evans include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jonathan Evans last invest?
The most recent investment recorded for Jonathan Evans closed in Aug 2018. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
